Companies / Akebia Therapeutics, Inc. / Activity

Activity — Akebia Therapeutics, Inc.

35 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 17, 2026Adams Adrian
Director
GrantCommon Stock$0+36K
+17.81%
236,200
0.09% of shares
low
Jun 17, 2026Rogers Michael W
Director
GrantCommon Stock$0+36K
+22.07%
197,429
0.07% of shares
low
Jun 17, 2026Zumwalt Leanne M
Director
GrantCommon Stock$0+36K
+32.63%
145,100
0.05% of shares
low
Jan 30, 2026Ostrowski Erik
Executive
GrantCommon Stock$0+204K
+40.51%
707,586
0.26% of shares
low
Jan 30, 2026Grund Nicholas
Executive
GrantCommon Stock$0+204K
+46.09%
646,579
0.23% of shares
low
Jan 30, 2026Burke Steven Keith
Executive
GrantCommon Stock$0+204K
+25.12%
1,016,090
0.37% of shares
low
Jan 30, 2026Butler John P.
CEO
GrantCommon Stock$0+743K
+27.31%
3,463,849
1.25% of shares
low
Jan 30, 2026Rucci Carolyn M.
Executive
GrantCommon Stock$0+190K
+40.59%
658,150
0.24% of shares
low
Jan 30, 2026Malabre Richard C
Executive
GrantCommon Stock$0+79K
+29.27%
348,914
0.13% of shares
low
Feb 2, 2026Malabre Richard C
Executive
SellCommon Stock$18.6K-13K
-4.28%
299,390
0.11% of shares
low
Feb 2, 2026Rucci Carolyn M.
Executive
SellCommon Stock$23.4K-17K
-2.56%
641,304
0.23% of shares
low
Feb 2, 2026Burke Steven Keith
Executive
SellCommon Stock$28.8K-21K
-2.14%
948,432
0.34% of shares
low
Feb 2, 2026Burke Steven Keith
Executive
SellCommon Stock$30.0K-22K
-2.12%
994,508
0.36% of shares
low
Feb 2, 2026Burke Steven Keith
Executive
SellCommon Stock$35.3K-25K
-2.55%
969,133
0.35% of shares
low
Feb 2, 2026Rucci Carolyn M.
Executive
SellCommon Stock$35.3K-25K
-3.96%
615,922
0.22% of shares
low
Feb 2, 2026Rucci Carolyn M.
Executive
SellCommon Stock$38.3K-28K
-4.47%
588,378
0.21% of shares
low
Feb 2, 2026Grund Nicholas
Executive
SellCommon Stock$43.4K-31K
-5.27%
561,750
0.20% of shares
low
Feb 2, 2026Ostrowski Erik
Executive
SellCommon Stock$48.6K-35K
-4.94%
672,635
0.24% of shares
low
Feb 2, 2026Malabre Richard C
Executive
SellCommon Stock$50.2K-36K
-10.36%
312,772
0.11% of shares
low
Feb 2, 2026Butler John P.
CEO
SellCommon Stock$64.9K-47K
-1.35%
3,417,189
1.23% of shares
low
Feb 2, 2026Grund Nicholas
Executive
SellCommon Stock$74.5K-54K
-8.29%
592,994
0.21% of shares
low
Mar 4, 2026Butler John P.
CEO
BuyCommon Stock$86.6K+69K
+2.10%
3,367,064
1.22% of shares
medium
Feb 2, 2026Butler John P.
CEO
SellCommon Stock$116.3K-84K
-2.47%
3,297,794
1.19% of shares
medium
Feb 2, 2026Butler John P.
CEO
SellCommon Stock$133.5K-96K
-2.81%
3,321,124
1.20% of shares
medium
Feb 2, 2026Butler John P.
CEO
SellCommon Stock$159.7K-115K
-3.46%
3,206,233
1.16% of shares
medium
Feb 2, 2026Butler John P.
CEO
GrantCommon Stock$247.1K+175K
+5.47%
3,381,483
1.22% of shares
low
Jun 17, 2026Adams Adrian
Director
GrantStock Option (Right to buy)—+54K
53,600
0.02% of shares
low
Jun 17, 2026Rogers Michael W
Director
GrantStock Option (Right to buy)—+54K
53,600
0.02% of shares
low
Jun 17, 2026Zumwalt Leanne M
Director
GrantStock Option (Right to buy)—+54K
53,600
0.02% of shares
low
Jan 30, 2026Ostrowski Erik
Executive
GrantStock Option (Right to buy)—+320K
320,000
0.12% of shares
low
Jan 30, 2026Grund Nicholas
Executive
GrantStock Option (Right to buy)—+320K
320,000
0.12% of shares
low
Jan 30, 2026Burke Steven Keith
Executive
GrantStock Option (Right to buy)—+320K
320,000
0.12% of shares
low
Jan 30, 2026Butler John P.
CEO
GrantStock Option (Right to buy)—+1.1M
1,115,000
0.40% of shares
low
Jan 30, 2026Rucci Carolyn M.
Executive
GrantStock Option (Right to buy)—+270K
270,000
0.10% of shares
low
Jan 30, 2026Malabre Richard C
Executive
GrantStock Option (Right to buy)—+119K
119,000
0.04% of shares
low
← PrevPage 1 of 1Next →